Fosamax Raises Bone Fracture Questions Among Patients

March 9, 2010

Fosamax raises bone fracture questions among patients

For much of the past decade, doctors have been prescribing women with osteoporosis and women who are osteopenic the prescription medication Fosamax. The drug, belonging to the class known as bisphosphonates, is intended to strengthen bones and combat the effects of bone diseases like osteoporosis by regenerating the bone. However, recent evidence, reports and allegations are showing that Fosamax’s side effects are leaving patients more prone to fractures and further bone damage.

Women using the drug for a period of more than five years, according to new studies and allegations, have been experiencing serious fractures. Doctors believe that at a certain point the body no longer responds to Fosamax and the human bones quit reacting to the prescription medication’s positive qualities, such as the ability to induce regeneration of the bones. Studies have shown in the past that the biosphosponates actually prevent serious fractures in the hip and spine, which have a higher chance of fatality for women.

Previously, Fosamax has been linked to two very serious bone injuries – severe musculoskeletal pain and osteonecrosis, which affects the jaw bone. These two types of bone injury and pain are examples of adverse reactions to the medication, or opposite effects for people who don’t experience the drug’s advantages. In 2008, the U.S. Food and Drug Administration responded to reports of fractures caused by Fosamax by making the drug’s manufacturer, Merck & Co., Inc., aware of these serious side effects. Merck responded by eventually adding femur fractures as a side effect to packaging and marketing material for Fosamax. The addition came after a study of patients taking the drug and lasted more than a year.

Fosamax and its similar drugs are serious moneymakers for the pharmaceutical industry, as sales of bone and osteoporosis drugs surpassed $3.5 billion in 2008, as prescriptions rose equally to more than 37 million in the U.S. Since awareness of these potential side effects has risen, Merck has maintained that it has kept consumers aware of the potential dangers.

Additional serious side effects and indicators of potentially dangerous health complications of Fosamax and related drugs include chest pain, difficulty with swallowing, chest pains and burning sensations including heartburn, intense joint and bone pain, and/or swelling in the jaw. More common side effects include mild heartburn, nausea, stomach pains, slight joint pains or swelling, swelling of the hands or feets, back pains, and/or dizziness and headaches.

If you or a loved one has experienced a serious side effect or symptoms of side effects related to Fosamax or similar drugs, contact Newsome Law Firm and fill out a case evaluation form today. Our team of attorneys has experience specific to complications associated with injuries associated with prescription medication. Not only can they give you the legal guidance you need, they can help you get the compensation you deserve.

Related Topics:

OVER $500,000,000 recovered
Newsome Melton has recovered over half a billion dollars for their clients.
Product Liability Lawyer - Newsome Melton

    Please do not navigate away from this page until you receive a success notification.

    Product Liability Lawyer - Newsome Melton